期刊文献+

凝血因子Ⅴ与出血和血栓的相关性研究进展 被引量:2

Research progress of coagulation factorⅤand its association with hemorrhage and thrombosis
在线阅读 下载PDF
导出
摘要 凝血因子(F)Ⅴ是调控并参与凝血初始反应的必需因子,对凝血酶的生成有极其重要的影响。最新研究发现FⅤ还具有抗凝特性。FⅤ基因(F5)的不同突变导致了出血或者血栓的形成。F5功能缺陷型突变常导致出血,如遗传性凝血因子Ⅴ缺陷症(FⅤD)患者多表现为不同程度的出血;但F5功能获得性突变则易形成血栓,如FⅤ_(Leiden)突变是高加索人群静脉血栓形成最常见的遗传危险因素。文章对FⅤ与出血和血栓相关性的研究进展进行综述。 Coagulation factor(F)Ⅴis an essential factor to participate in the initial phase of coagulation,which plays a role in the production of thrombin.It is recently suggested that FⅤalso harbors anticoagulant properties.Different mutations in the FⅤgene(F5)cause bleeding or thrombosis.F5 dysfunction mutations often lead to bleeding.For example,patients with hereditary coagulation factorⅤdeficiency(FⅤD)often show different degrees of bleeding.However,F5 gain-of-function mutations are prone to thrombosis.FⅤ_(Leiden) mutation is the most common genetic risk factor for venous thrombosis in Caucasians.This review mainly focuses on the research progress of the association of FⅤwith hemorrhage and thrombosis.
作者 李可可 肖扬 LI Keke;XIAO Yang(Dongguan Tungwah Hospital,Dongguan,523129,Guangdong,China;Shenzhen Qianhai Shekou Free Trade Zone Hospital,Shenzhen 518067,Guangdong,China)
出处 《检验医学》 CAS 2022年第4期396-399,共4页 Laboratory Medicine
关键词 凝血因子Ⅴ F5突变 凝血因子Ⅴ缺陷症 表型 基因型 Coagulation factorⅤ F5 mutation Coagulation factorⅤdeficiency Phenotype Genotype
  • 相关文献

参考文献2

二级参考文献18

  • 1Jenny RJ, Pittman DD, Toole JJ. et al. Complete cDNA and derived amino acid sequence of human factor V. Proc Natl Acad Sci U S A,1987,4:4846-4850.
  • 2van Wijk R, Nieuwenhuis K, van den Berg M, et al. Five novel mutations in the gene for human blood coagulation factor V associated with type I factor V deficiency. Blood,2001,98:358-367.
  • 3Guasch JF, Cannegieter S, Reitsma PH. et al. Severe coagulation factor V deficiency caused by a 4 bp deletion in the factor V gene. Br J Haematol,1998,101:32-39.
  • 4Guasch JF, Lensen RP, Bertina RM.Molecular characterization of a type I quantitative factor V deficiency in a thrombosis patient that is "pseudo homozygous" for activated protein C resistance. Thromb Haemost,1997,77:252-257.
  • 5Murray JM, Rand MD, Egan JO. et al. Factor V New Brunswick: Ala221-to-Val substitution results in reduced cofactor activity.Blood,1995,86:1820-1827.
  • 6Castoldi E, Kalafatis M, Lunghi B. et al. Molecular bases of pseudo-homozygous APC resistance: the compound heterozygosity for FV R506Q and a FV null mutation results in the exclusive presence of FV Leiden molecules in plasma. Thromb Haemost,1998,80:403-406.
  • 7Mirochnik O, Halim-Kertanegara N, Henniker AJ, et al. A novel factor V null mutation at Arg 506 causes a false positive factor V Leiden result. Thromb Haemost,1999,82:1198-1199.
  • 8Zehnder JL, Hiraki DD, Jones CD, et al. Familial coagulation factor V deficiency caused by a novel 4 base pair insertion in the factor V gene: factor V Stanford. Thromb Haemost,1999,82:1097-1099.
  • 9Castoldi E, Simioni P, Kalafatis M, et al. Combinations of 4 mutations (FV R506Q, FV H1299R, FV Y1702C, PT 20210G/A) affecting the prothrombinase complex in a thrombophilic family. Blood, 2000,96:1443-1448.
  • 10Montefusco MC, Duga S, Asselta R, et al. A novel two base pair deletion in the factor V gene associated with severe factor V deficiency. Br J Haematol,2000,111:1240-1246.

共引文献5

同被引文献29

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部